Parenteral Drugs to relocate its plant to Asrawad
Parenteral Drugs is relocating its plant from Asrawad in Indore to Kharghone. The plant is being relocated from Village Asrawad, Post Dudhia, Nemawar Road, dist. […]
Parenteral Drugs is relocating its plant from Asrawad in Indore to Kharghone. The plant is being relocated from Village Asrawad, Post Dudhia, Nemawar Road, dist. […]
Aurobindo Pharma Ltd has received final approval from USFDA to manufacture and market Famotidine Tablets used for acid reflux treatment. The approval has been granted […]
SMS Pharmaceuticals has received approval from the USFDA for manufacturing facility in Kandivalasa in Visakhapatnam district of Andhra Pradesh. The USFDA had conducted inspection of […]
Cipla Ltd has launched the generic version of anti-hepatitis drug Ledipasvir-Sofosbuvir in the domestic market. The drug is used for treating hepatitis C virus. About […]
Hetero Drugs has received approval from DCGI to market generic version of Gilead’s Harvoni, a drug used in the treatment of Hepatitis C, in the […]
Jubilant Life Sciences Ltd has received final approval from USFDA for its generic version of anti-depressant Paxil tablets. The final approval for the abbreviated new […]
AstraZeneca Pharma India (AZPIL) the subsidiary of British-Swedish multinational pharmaceutical and biologics company AstraZeneca, has shut down its Active Pharmaceutical Ingredient (API) unit in Bengaluru. […]
Glenmark Pharmaceuticals has received the USFDA final approval for its anti-bacterial drug Zyvox. The product is the therapeutic equivalent of Zyvox tablets, 600 mg of […]
Granules India Ltd has completed inspection formalities for USFDA inspections in its Vizag plant in Andhra Pradesh. It has not received any observation, while its […]
Karnataka government is planning to setup a pharma park in Mudipu in Mangalore in Dakshina Kannada district in Karnataka. The state government will provide 100 […]
Copyright © 2024 | WordPress Theme by MH Themes